Retinal Degeneration Clinical Trial
Official title:
Measuring Reading Rehabilitation Outcomes
Verified date | December 2006 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with age-related macular degeneration.
Status | Completed |
Enrollment | 90 |
Est. completion date | May 2008 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients with a diagnosis of AMD - An established preferred retinal locus - Visual acuity of less than or equal to 20/70 and greater than or equal to 20/400 (in the better eye) Exclusion Criteria: - Those with other major ophthalmologic and neurologic disease; choroidal neovascularization ("wet" AMD); moderate to severe media opacities; and cognitive impairment |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind
Country | Name | City | State |
---|---|---|---|
United States | Jesse Brown VA Medical Center | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Szlyk JP, Paliga J, Seiple W, Rabb MF. Comprehensive functional vision assessment of patients with North Carolina macular dystrophy (MCDR1). Retina. 2005 Jun;25(4):489-97. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Participants will be given the following assessment tests at 4 different times during the assessment (at baseline, after 6 weeks, after 12 weeks, and after 18 weeks): eye tracking measures, daily performance measures and reading measures. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01432847 -
Cell Collection to Study Eye Diseases
|
||
Terminated |
NCT03561922 -
Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS
|
N/A | |
Active, not recruiting |
NCT03872479 -
Single Ascending Dose Study in Participants With LCA10
|
Phase 1/Phase 2 | |
Completed |
NCT00231010 -
Molecular Genetics of Retinal Degenerations
|
||
Recruiting |
NCT03078309 -
The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients
|
Early Phase 1 | |
Active, not recruiting |
NCT01736293 -
Natural History of Eye Diseases Related to ABCA4 Mutations
|
||
Completed |
NCT03318549 -
BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases
|
N/A | |
Completed |
NCT04919473 -
Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa
|
Phase 1/Phase 2 | |
Completed |
NCT03321253 -
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification
|
N/A | |
Completed |
NCT01497379 -
Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
|
N/A | |
Recruiting |
NCT04620876 -
Bimodal and Coaxial High Resolution Ophtalmic Imaging
|
N/A | |
Recruiting |
NCT03592017 -
Performance of Long-wavelength Autofluorescence Imaging
|
N/A | |
Completed |
NCT03150654 -
The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes
|
N/A | |
Recruiting |
NCT04545736 -
Oral Metformin for Treatment of ABCA4 Retinopathy
|
Phase 1/Phase 2 | |
Completed |
NCT00403195 -
Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
|
N/A | |
Enrolling by invitation |
NCT06167642 -
Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
|
||
Enrolling by invitation |
NCT02144103 -
Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration
|
Phase 1/Phase 2 | |
Recruiting |
NCT06289452 -
Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis
|
Early Phase 1 | |
Recruiting |
NCT06305416 -
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
|
Phase 3 | |
Recruiting |
NCT02617966 -
Rod and Cone Mediated Function in Retinal Disease
|